Teratogenesis, teratogens and critical periods

Teratogenesis refers to the process by which external or internal factors cause abnormal development in the embryo or fetus, leading to congenital anomalies or birth defects. The agents that produce these abnormalities are called teratogens. The timing during which the embryo or fetus is most vulnerable to these influences is known as a critical period.

Teratogenesis

Teratogenesis includes any mechanism that disrupts normal developmental processes, resulting in structural, functional, metabolic or behavioral abnormalities. These disturbances most commonly occur during organogenesis (Weeks 3-8), when the embryo's organs and tissues are forming and therefore highly sensitive to outside influences.

Teratogens

Teratogens are agents capable of causing congenital anomalies. Their effects depend on the dosage, duration of exposure, maternal health, genetics susceptibility and especially the timing of exposure.

Infectious teratogens

• Rubella virus, which may cause cataracts, cardiac defects and hearing loss.
• Toxoplasma gondii, which can lead to hydrocephalus and chorioretinitis.
• Cytomegalovirus (CMV), associated with microcephaly and hearing impairment.

Chemical and drug teratogens

• Alcohol, which causes fetal alcohol disorders.
• Isotretinoin (Accutane), which can lead to craniofacial, cardiac and thymic anomalies.
• Thalidomide, known for causing limb reduction defects.
• Certain anticoagulants that increase the risk of neural tube defects.

Physical teratogens

• Ionizing radiation, which may produce skeletal defects or microcephaly.
• Hyperthermia, which can cause neural tube defects.

Maternal conditions

• Maternal diabetes, strongly associated with cardiac defects, neural tube defects and caudal regression.
• Poorly controlled phenylketonuria, which may result in microcephaly and congenital heart disease.

Multifactorial influences

Many developmental anomalies result from a combination of genetics predisposition and environmental exposure.

Mechanisms of Teratogenic Action

Teratogens may disrupt normal development through several mechanisms:

• Excessive or abnormal programmed cell death.
• Reduced or failed cell proliferation.
• Problems with cell migration, particularly in neural crest cells.
• Failure of tissue interactions or induction during organ formation.
• Mechanical disruption, such as amniotic bands affecting limb development.

These mechanisms illustrate how both intrinsic and extrinsic factors influence morphogenesis.

Critical Periods of Development

The impact of a teratogen depends heavily on the developmental stage at which exposure occurs.

Pre-implantation period (0-2 weeks)

This is often called the all-or-none period. Exposure to harmful substances typically either results in embryonic loss or causes no lasting anomaly, because the cells are totipotent and capable of compensating.

Embryonic period (3-8 weeks)

This is the most sensitive stage of development. As organogenesis occurs during this window, exposure to teratogens can lead to major structural anomalies, including neural tube defects, heart malformations and limb abnormalities.

Fetal period (after 8 weeks)

After organogenesis, the risk of major structural anomalies is lower. However, the fetus remains vulnerable to:

• functional disorders
• minor structural issues
• growth disturbances
• metabolic or endocrine problems

Clinical Relevance

Fetal Alcohol Disorder

Fetal alcohol disorders remain one of the most common preventable causes of intellectual disability. Teratogenic medications require caution and counseling for individuals who may become pregnant. Preventative measures, such as adequate folic acid supplementation significantly reduces the risk of neural tube defects.

Resources

1. Sadler, T. W. Langman’s Medical Embryology, 14th edition
2. Junqueira, L. C., Carneiro, J. Basic Histology: Text and Atlas, 15th edition
3. Moore, K. L., Persaud, T. V. N., & Torchia, M. G. The Developing Human: Clinically Oriented Embryology.
4. Moore, K. L. The Developing Human.